Interactions between prolactin and immune processes.
Di Carlo
R
R
Department of Experimental Pharmacology, University of Naples Federico II.
Meli
R
R
D000328:Adult; D000818:Animals; D001921:Brain / Q000378:metabolism; D002351:Carrageenan / Q000633:toxicity; D004487:Edema / Q000139:chemically induced / Q000503:physiopathology; D006801:Humans; D006966:Hyperprolactinemia / Q000503:physiopathology; D007031:Hypothalamus / Q000378:metabolism; D007231:Infant, Newborn; D007249:Inflammation / Q000503:physiopathology; D007668:Kidney; D008214:Lymphocytes / Q000378:metabolism; D015213:Neuroimmunomodulation / Q000502:physiology*; D010902:Pituitary Gland / Q000637:transplantation; D010998:Pleurisy / Q000139:chemically induced / Q000503:physiopathology; D011388:Prolactin / Q000378:metabolism / Q000502:physiology*; D011817:Rabbits; D051381:Rats; D011981:Receptors, Prolactin / Q000378:metabolism / Q000502:physiology; D016042:Transplantation, Heterotopic
D011981:Receptors, Prolactin; D002351:Carrageenan; D011388:Prolactin